Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract
In this study, l-131-MIBG imaging was performed in 44 patients with clinical suspicion of tumors originating from neuro-endocrine system. The patients were referred to our department following plasma and urinary measurement of epinephrine, norepinehrine and vanilmandelic acidfVMA). Radionuclide imaging was performel as a comparative or confirmatory measure in all patients who had previous abdominal sonography and CT scan: This study emphasizes that MIBG imaging is a non-invasive, sensitive, and specially specific method for evaluation of primary, metastatic, and recurrent neuro-endocrine (APUD) tumors.
Eftekhari, M., Rashidi, B., & Alavi, M. (1995). 131I-MIBG imaging in evaluation of neuro-endocrine (APUD) tumors [Persian]. Iranian Journal of Nuclear Medicine, 3(1), 8-11.
MLA
Meftekhari Eftekhari; Borzoo Rashidi; Mehrosadat Alavi. "131I-MIBG imaging in evaluation of neuro-endocrine (APUD) tumors [Persian]". Iranian Journal of Nuclear Medicine, 3, 1, 1995, 8-11.
HARVARD
Eftekhari, M., Rashidi, B., Alavi, M. (1995). '131I-MIBG imaging in evaluation of neuro-endocrine (APUD) tumors [Persian]', Iranian Journal of Nuclear Medicine, 3(1), pp. 8-11.
VANCOUVER
Eftekhari, M., Rashidi, B., Alavi, M. 131I-MIBG imaging in evaluation of neuro-endocrine (APUD) tumors [Persian]. Iranian Journal of Nuclear Medicine, 1995; 3(1): 8-11.
)